Scott Dunseth Myers - Jun 22, 2023 Form 4 Insider Report for Harpoon Therapeutics, Inc. (HARP)

Role
Director
Signature
/s/ Scott Myers by Frank J. Lanza, Attorney-in-Fact
Stock symbol
HARP
Transactions as of
Jun 22, 2023
Transactions value $
$0
Form type
4
Date filed
6/23/2023, 04:36 PM
Previous filing
May 31, 2023
Next filing
Jul 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HARP Director Stock Option (Right to Buy) Award $0 +46K $0.00 46K Jun 22, 2023 Common Stock 46K $0.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will fully vest and become exercisable on June 21, 2024, subject to the continuous service of the Reporting Person with the Issuer on such date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney